BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/6/2023 10:35:23 AM | Browse: 354 | Download: 1222
Publication Name World Journal of Clinical Cases
Manuscript ID 80934
Country China
Received
2022-10-20 09:14
Peer-Review Started
2022-10-20 09:18
First Decision by Editorial Office Director
2023-02-07 08:49
Return for Revision
2023-02-07 08:49
Revised
2023-02-19 09:16
Publication Fee Transferred
Editorial Processing by Scientific Editor
2023-03-20 03:15
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2023-03-20 09:11
Articles in Press
2023-03-20 09:11
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-03-23 10:30
Publish the Manuscript Online
2023-04-06 10:35
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Case Report
Article Title Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report
Manuscript Source Unsolicited Manuscript
All Author List Jia-Ping Qi, Huan Jiang, Teng Wu, Yuan Zhang, Wei Huang, Yi-Xuan Li, Jing Wang, Ju Zhang and Zhen-Hua Ying
ORCID
Author(s) ORCID Number
Zhen-Hua Ying http://orcid.org/0000-0002-5443-3675
Funding Agency and Grant Number
Corresponding Author Zhen-Hua Ying, MM, Chief Doctor, Professor, Teacher, Center for General Practice Medicine, Department of Rheumatology and Immunology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, No. 158, Shangtang Road, Hangzhou 310000, Zhejiang Province, China. yingzh2021@163.com
Key Words Difficult-to-treat rheumatoid arthritis; Abatacept; Baricitinib; Combination therapy; Case report
Core Tip Although the combined use of Abatacept (ABT) and Janus kinase (JAK) inhibitors is not recommended in rheumatoid arthritis (RA) treatment guidelines, inflammatory cytokines have been found to compensate for the inhibitory effect of ABT on co-stimulatory signals, activate T-lymphocytes through the JAK/ Signal Transducers and Activators of Transcription (STAT) pathway, and promote the inflammatory response. In the treatment of this patient, Baricitinib, as a JAK inhibitor, combined with ABT can be used as a rescue treatment for difficult-to-treat RA, especially for patients with poor responses to single ABT treatment.
Publish Date 2023-04-06 10:35
Citation Qi JP, Jiang H, Wu T, Zhang Y, Huang W, Li YX, Wang J, Zhang J, Ying ZH. Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report. World J Clin Cases 2023; 11(11): 2474-2481
URL https://www.wjgnet.com/2307-8960/full/v11/i11/2474.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i11.2474
Full Article (PDF) WJCC-11-2474.pdf
Full Article (Word) WJCC-11-2474.docx